Antifungal Resistance to Fluconazole and Echinocandins Is Not Emerging in Yeast Isolates Causing Fungemia in a Spanish Tertiary Care Center
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifungal Resistance to Fluconazole and Echinocandins Is Not Emerging in Yeast Isolates Causing Fungemia in a Spanish Tertiary Care Center
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 8, Pages 4565-4572
Publisher
American Society for Microbiology
Online
2014-05-28
DOI
10.1128/aac.02670-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global trends in the distribution of Candida species causing candidemia
- (2014) J. Guinea CLINICAL MICROBIOLOGY AND INFECTION
- Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
- (2014) Maiken C. Arendrup et al. DRUG RESISTANCE UPDATES
- Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011
- (2013) Jesús Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain
- (2013) M. Puig-Asensio et al. CLINICAL MICROBIOLOGY AND INFECTION
- Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
- (2012) J. Peman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Echinocandin Susceptibility Testing ofCandidaspp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots
- (2011) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Identification of Closely Related Candida Species Using Two Ribosomal Intergenic Spacer Fingerprinting Methods
- (2011) Muriel Cornet et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Variación de la epidemiología de las fungemias y de la sensibilidad al fluconazol de los aislamientos de hemocultivos en los últimos 10 años en España: resultados del estudio FUNGEMYCA
- (2011) Javier Pemán et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin
- (2010) M. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- National Surveillance of Fungemia in Denmark (2004 to 2009)
- (2010) M. C. Arendrup et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing
- (2008) M. Desnos-Ollivier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
- (2008) J.L. Rodriguez-Tudela et al. CLINICAL MICROBIOLOGY AND INFECTION
- Molecular Identification of Candida orthopsilosis Isolated from Blood Culture
- (2008) P. V. C. Yong et al. MYCOPATHOLOGIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started